Juvenile Idiopathic Arthritis

Guidelines

2021 JIA Guidelines

JIA Oligoarthritis, TMJ, and sJIA
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis

Documents related to the 2021 JIA oligoarthritis, TMJ, and sJIA guideline:

• Appendix 1 - Methods
• Appendix 2 - Search Strategies
• Appendix 3 - Evidence Report
• Appendix 4 - List of Outcomes
• Appendix 5 - Panels/Teams Involved
• Appendix 6 - Study Selection
• Appendix 7 - Research Agenda
• ACR Juvenile Idiopathic Arthritis Guideline Project Plan
• ACR Juvenile Idiopathic Arthritis Public Comments
• ACR Juvenile Idiopathic Arthritis Guideline Author Response to Public Comments

JIA Nonpharmacologic, Medication Monitoring, Immunizations, and Imaging
2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging

Documents related to the 2021 JIA nonpharmacologic, medication monitoring, immunizations, and imaging guideline:

• Appendix 1 - Methods
• Appendix 2 - Search Strategies
• Appendix 3 - Evidence Report
• Appendix 4 - List of Outcomes
• Appendix 5 - Panels/Teams Involved
• Appendix 6 - Study Selection
• Appendix 7 - Research Agenda

2019 JIA Guidelines

JIA
American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis - 2019

Documents related to the 2019 JIA guideline:

• JIA Guideline Appendix 1 - Methods
• JIA Guideline Appendix 2 - Panel Teams
• JIA Guideline Appendix 3 - Outcomes Framework
• JIA Guideline Appendix 4 - Search Strategies
• JIA Guideline Appendix 5 - Study Selection
• JIA Guideline Appendix 6 - Evidence Report
• JIA Guideline Disclosure Summary
• JIA Guideline Project Plan
• JIA Guideline Public Comments
• JIA Guideline Author Response to Public Comments

JIA Uveitis
American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis - 2019

Documents related to the 2019 JIA uveitis guideline:

• JIA Uveitis Guideline Appendix 1 - Methods
• JIA Uveitis Guideline Appendix 2 - Panel Teams
• JIA Uveitis Guideline Appendix 3 - Search Strategies
• JIA Uveitis Guideline Appendix 4 - Study Selection
• JIA Uveitis Guideline Appendix 5 - Evidence Report Selection
• JIA Uveitis Guideline Appendix 6 - Dropped PICO Questions
• JIA Uveitis Guideline Disclosure Summary

2013 JIA Guideline

2013 Update of 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis

Documents related to the 2013 JIA guideline:

• JIA Guideline Project Plan
• JIA Guideline Summary of Disclosures
• JIA Guideline Public Comments
• JIA Guideline Author Response to Public Comments

2011 JIA Guideline

American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis - 2011

Clinician Guide - 2011